We Need to Talk About Postpartum Anxiety: Have Questions? Want Answers? Join Us on Our Podcast
We are looking to connect with moms who have experienced postpartum anxiety to join us on our podcast "So Glad You Asked". Join us!
Clinical Update 2024: Gabapentin (Neurontin) and Pregnancy
In this study with over 4000 infants exposed to gabapentin, the information is reassuring. While we cannot rule out the possibility of a small increase in risk of cardiovascular malformations in gabapentin-exposed infants, gabapentin does not appear to be a major teratogen.Â
Is it Safe for Breastfeeding Mothers to Use Benzodiazepines?
Clinically significant anxiety symptoms are common during the postpartum period and frequently complicate the treatment of postpartum depression.  While SSRIs are indicted for the treatment anxiety symptoms, especially when they co-occur with depression, many women may need to use a benzodiazepine for managing more severe symptoms of anxiety or insomnia.Â
Mind-Body Therapies for the Treatment of Depression, Anxiety and PTSD in Women Victims of Violence
This meta-analysis suggests that mind-body therapies are an effective treatment for women victims of violence.
CBT and Mindfulness-Based Interventions for the Treatment of Anxiety and Depression in Perimenopausal Women
This review and meta-analysis reviews the effectiveness of cognitive behavioral therapy and mindfulness interventions for depression, anxiety, and cognitive functioning in women undergoing menopausal transition. Â
Anxiety and Depression in Expectant Parents Conceiving with ART Versus Conceiving Spontaneously
Overall, parents who conceive through ART experience lower levels of anxiety and depression compared to parents who conceive spontaneously.
Essential Reads: The Use of Sedative-Hypnotic Drugs During Pregnancy
More study is needed regarding the safety of sedative-hypnotic medications during pregnancy.
Single Day CBT-Based Workshops for Mothers with Postpartum Depression
In this randomized controlled trial, a CBT-based workshop for women with PPD led to clinically meaningful reductions in depression and anxiety.
Zuranolone Improves Anxiety Symptoms and Insomnia in Women with Postpartum Depression
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.
Understanding the Impact of the COVID-19 Pandemic on the Psychological Well-Being of Individuals Undergoing Infertility TreatmentÂ
Women undergoing infertility treatment, as well as women who conceived after infertility, experienced significant levels of distress as a result of the COVID-10 pandemic.